Literature DB >> 20832369

Clinical and immunological overlap between autoimmune lymphoproliferative syndrome and common variable immunodeficiency.

A Rensing-Ehl1, K Warnatz, S Fuchs, M Schlesier, U Salzer, R Draeger, I Bondzio, Y Joos, A Janda, M Gomes, M Abinun, S Hambleton, A Cant, F Shackley, T Flood, C Waruiru, K Beutel, K Siepermann, G Dueckers, T Niehues, T Wiesel, V Schuster, M G Seidel, M Minkov, K Sirkiä, M V Kopp, M Korhonen, K Schwarz, S Ehl, C Speckmann.   

Abstract

Autoimmune lymphoproliferative syndrome (ALPS) is mainly caused by defects in the CD95 pathway. Raised CD3+TCRαβ+CD4-CD8- double negative T cells and impaired T cell apoptosis are hallmarks of the disease. In contrast, the B cell compartment has been less well studied. We found an altered distribution of B cell subsets with raised transitional B cells and reduced marginal zone B cells, switched memory B cells and plasma blasts in most of 22 analyzed ALPS patients. Moreover, 5 out of 66 ALPS patients presented with low IgG and susceptibility to infection revealing a significant overlap between ALPS and common variable immunodeficiency (CVID). In patients presenting with lymphoproliferation, cytopenia, hypogammaglobulinemia and impaired B cell differentiation, serum biomarkers were helpful in addition to apoptosis tests for the identification of ALPS patients. Our observations may indicate a role for apoptosis defects in some diseases currently classified as CVID.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20832369     DOI: 10.1016/j.clim.2010.08.008

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  21 in total

1.  Progression of Common Variable Immunodeficiency Interstitial Lung Disease Accompanies Distinct Pulmonary and Laboratory Findings.

Authors:  Paul J Maglione; Jessica R Overbey; Charlotte Cunningham-Rundles
Journal:  J Allergy Clin Immunol Pract       Date:  2015-09-12

Review 2.  How I treat autoimmune lymphoproliferative syndrome.

Authors:  V Koneti Rao; João Bosco Oliveira
Journal:  Blood       Date:  2011-09-01       Impact factor: 22.113

3.  A mutation in caspase-9 decreases the expression of BAFFR and ICOS in patients with immunodeficiency and lymphoproliferation.

Authors:  N Clemente; E Boggio; C L Gigliotti; E Orilieri; G Cappellano; E Toth; P A Valletti; C Santoro; I Quinti; C Pignata; L D Notarangelo; C Dianzani; I Dianzani; U Ramenghi; U Dianzani; A Chiocchetti
Journal:  Genes Immun       Date:  2015-01-08       Impact factor: 2.676

4.  A rapid ex vivo clinical diagnostic assay for fas receptor-induced T lymphocyte apoptosis.

Authors:  Bernice Lo; Madhu Ramaswamy; Joie Davis; Susan Price; V Koneti Rao; Richard M Siegel; Michael J Lenardo
Journal:  J Clin Immunol       Date:  2012-10-11       Impact factor: 8.317

5.  Antiviral and regulatory T cell immunity in a patient with stromal interaction molecule 1 deficiency.

Authors:  Sebastian Fuchs; Anne Rensing-Ehl; Carsten Speckmann; Bertram Bengsch; Annette Schmitt-Graeff; Ilka Bondzio; Andrea Maul-Pavicic; Thilo Bass; Thomas Vraetz; Brigitte Strahm; Tobias Ankermann; Melina Benson; Almuth Caliebe; Regina Fölster-Holst; Petra Kaiser; Robert Thimme; Wolfgang W Schamel; Klaus Schwarz; Stefan Feske; Stephan Ehl
Journal:  J Immunol       Date:  2011-12-21       Impact factor: 5.422

Review 6.  Autoimmune and Lymphoproliferative Complications of Common Variable Immunodeficiency.

Authors:  Paul J Maglione
Journal:  Curr Allergy Asthma Rep       Date:  2016-03       Impact factor: 4.806

7.  Sequential decisions on FAS sequencing guided by biomarkers in patients with lymphoproliferation and autoimmune cytopenia.

Authors:  Anne Rensing-Ehl; Ales Janda; Myriam R Lorenz; Beryl P Gladstone; Ilka Fuchs; Mario Abinun; Michael Albert; Karina Butler; Andrew Cant; Anna-Maria Cseh; Martin Ebinger; Sigune Goldacker; Sophie Hambleton; Holger Hebart; Leonora Houet; Karim Kentouche; Ingrid Kühnle; Kai Lehmberg; Ester Mejstrikova; Charlotte Niemeyer; Milen Minkov; Olaf Neth; Gregor Dückers; Stephan Owens; Joachim Rösler; Freimut H Schilling; Volker Schuster; Markus G Seidel; Petr Smisek; Martina Sukova; Peter Svec; Thomas Wiesel; Benjamin Gathmann; Klaus Schwarz; Werner Vach; Stephan Ehl; Carsten Speckmann
Journal:  Haematologica       Date:  2013-07-12       Impact factor: 9.941

Review 8.  The Autoimmune Lymphoproliferative Syndrome with Defective FAS or FAS-Ligand Functions.

Authors:  Frédéric Rieux-Laucat; Aude Magérus-Chatinet; Bénédicte Neven
Journal:  J Clin Immunol       Date:  2018-06-17       Impact factor: 8.317

Review 9.  Cytopenia and autoimmune diseases: a vicious cycle fueled by mTOR dysregulation in hematopoietic stem cells.

Authors:  Pan Zheng; Xing Chang; Qianjin Lu; Yang Liu
Journal:  J Autoimmun       Date:  2013-02-01       Impact factor: 7.094

Review 10.  Autoimmune and other cytopenias in primary immunodeficiencies: pathomechanisms, novel differential diagnoses, and treatment.

Authors:  Markus G Seidel
Journal:  Blood       Date:  2014-08-27       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.